Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1973 May;32(3):238–246. doi: 10.1136/ard.32.3.238

Clinical and laboratory aspects of raised virus antibody titres in systemic lupus erythematosus.

N F Rothfield, A S Evans, J C Niederman
PMCID: PMC1006086  PMID: 4351822

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dalldorf G., Carvalho R. P., Jamra M., Frost P., Erlich D., Marigo C. The lymphomas of Brazilian children. JAMA. 1969 May 26;208(8):1365–1368. [PubMed] [Google Scholar]
  2. Evans A. S., Rothfield N. F., Niederman J. C. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971 Jan 23;1(7691):167–168. doi: 10.1016/s0140-6736(71)91937-4. [DOI] [PubMed] [Google Scholar]
  3. Evans A. S. The spectrum of infections with Epstein-Barr virus: a hypothesis. J Infect Dis. 1971 Sep;124(3):330–337. doi: 10.1093/infdis/124.3.330. [DOI] [PubMed] [Google Scholar]
  4. Feltkamp T. E., van Loghem J. J., Lucas C. J., van der Noordaa J., de Rooy D. J., ten Veen J. H. Antibodies to D.N.A. and viruses. Lancet. 1971 Jun 5;1(7710):1182–1182. doi: 10.1016/s0140-6736(71)91689-8. [DOI] [PubMed] [Google Scholar]
  5. Grumet F. C., Coukell A., Bodmer J. G., Bodmer W. F., McDevitt H. O. Histocompatibility (HL-A) antigens associated with systemic lupus erythematosus. A possible genetic predisposition to disease. N Engl J Med. 1971 Jul 22;285(4):193–196. doi: 10.1056/NEJM197107222850403. [DOI] [PubMed] [Google Scholar]
  6. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hollinger F. B., Sharp J. T., Lidsky M. D., Rawls W. E. Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum. 1971 Jan-Feb;14(1):1–11. doi: 10.1002/art.1780140102. [DOI] [PubMed] [Google Scholar]
  8. Howie J. B., Helyer B. J. The immunology and pathology of NZB mice. Adv Immunol. 1968;9:215–266. doi: 10.1016/s0065-2776(08)60444-7. [DOI] [PubMed] [Google Scholar]
  9. Hurd E. R., Dowdle W., Casey H., Ziff M. Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum. 1972 May-Jun;15(3):267–274. doi: 10.1002/art.1780150308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kalliomäki J. L., Halonen P. Antibody levels to parainfluenza, herpes simplex, varicella-zoster, cytomegalo virus, and measles virus in patients with connective tissue diseases. Ann Rheum Dis. 1972 May;31(3):192–195. doi: 10.1136/ard.31.3.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levy J. A., Pincus T. Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science. 1970 Oct 16;170(3955):326–327. doi: 10.1126/science.170.3955.326. [DOI] [PubMed] [Google Scholar]
  12. Liebhaber H. Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum. J Immunol. 1970 Apr;104(4):826–834. [PubMed] [Google Scholar]
  13. Lilly F. The histocompatibility-2 locus and susceptibility to tumor induction. Natl Cancer Inst Monogr. 1966 Sep;22:631–642. [PubMed] [Google Scholar]
  14. Mellors R. C., Shirai T., Aoki T., Huebner R. J., Krawczynski K. Wild-type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med. 1971 Jan 1;133(1):113–132. doi: 10.1084/jem.133.1.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Norton W. L. Endothelial inclusions in active lesions of systemic lupus erythematosus. J Lab Clin Med. 1969 Sep;74(3):369–379. [PubMed] [Google Scholar]
  16. PLOTZ C. M., SINGER J. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med. 1956 Dec;21(6):888–892. [PubMed] [Google Scholar]
  17. Phillips P. E., Christian C. L. Myxovirus antibody increases in human connective tissue disease. Science. 1970 May 22;168(3934):982–984. doi: 10.1126/science.168.3934.982. [DOI] [PubMed] [Google Scholar]
  18. ROTHFIELD N. F., PHYTHYON J. M., McEWEN C., MIESCHER P. The role of antinuclear reactions in the diagnosis of systemic lupus erythematosus: a study of 53 cases. Arthritis Rheum. 1961 Jun;4:223–239. doi: 10.1002/art.1780040302. [DOI] [PubMed] [Google Scholar]
  19. Rothfield N. F., Stollar B. D. The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest. 1967 Nov;46(11):1785–1794. doi: 10.1172/JCI105669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schmid F. R., Roitt I. M., Rocha M. J. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration. J Exp Med. 1970 Oct 1;132(4):673–693. doi: 10.1084/jem.132.4.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  22. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]
  23. Ziff M. Viruses and the connective tissue diseases. Ann Intern Med. 1971 Dec;75(6):951–958. doi: 10.7326/0003-4819-75-6-951. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES